Country: United States
Language: English
Source: NLM (National Library of Medicine)
FLUOXETINE HYDROCHLORIDE (UNII: I9W7N6B1KJ) (FLUOXETINE - UNII:01K63SUP8D)
Aidarex Pharmaceuticals LLC
ORAL
PRESCRIPTION DRUG
Fluoxetine capsules, USP are indicated for the acute and maintenance treatment of Major Depressive Disorder in adult patients and in pediatric patients aged 8 to 18 years [see Clinical Studies (14.1) ]. The usefulness of the drug in adult and pediatric patients receiving fluoxetine for extended periods, should periodically be re-evaluated [see Dosage and Administration (2.1) ] . Fluoxetine capsules, USP are indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with Obsessive Compulsive Disorder (OCD) [see Clinical Studies (14.2) ]. The effectiveness of fluoxetine capsules, USP in long-term use, i.e., for more than 13 weeks, has not been systematically evaluated in placebo-controlled trials. Therefore, the physician who elects to use fluoxetine capsules, USP for extended periods, should periodically re-evaluate the long-term usefulness of the drug for the individual patient [see Dosage and Administration (2.2) ]. Fluoxeti
Repackaged by: Aidarex Pharmaceuticals, LLC Corona, CA 92880 Fluoxetine capsules, USP 40 mg * are green opaque cap with orange opaque body, hard gelatin #2 capsules filled with white to off-white powder, imprinted with “RX632” on the cap and body in black ink. They are available as follows: NDC 33261-0883-30 Bottles of 30 NDC 33261-0883-60 Bottles of 60 * Fluoxetine base equivalent – present as the hydrochloride. Protect from light. Dispense in a tight, light-resistant container. Store at 20° - 25° C (68° - 77° F) [See USP Controlled Room Temperature].
Abbreviated New Drug Application
Aidarex Pharmaceuticals LLC ---------- MEDICATION GUIDE Revised: 12/2017 Document Id: 868cf43c-6ce2-49d0-b94f-039efab76e9c 34391-3 Set id: eb231077-fa47-4469-b3c5-4e13d2365252 Version: 3 Effective Time: 20171222 Aidarex Pharmaceuticals LLC Read the complete document
FLUOXETINE- FLUOXETINE CAPSULE AIDAREX PHARMACEUTICALS LLC ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE FLUOXETINE CAPSULES, USP SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR FLUOXETINE CAPSULES, USP. FLUOXETINE CAPSULES, USP FOR ORAL USE INITIAL U.S. APPROVAL: 1987 WARNING: SUICIDAL THOUGHTS AND BEHAVIORS _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING._ INCREASED RISK OF SUICIDAL THINKING AND BEHAVIOR IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS TAKING ANTIDEPRESSANTS (5.1). MONITOR FOR WORSENING AND EMERGENCE OF SUICIDAL THOUGHTS AND BEHAVIORS (5.1). _WHEN USING FLUOXETINE AND OLANZAPINE IN COMBINATION, ALSO REFER TO BOXED WARNING SECTION OF THE PACKAGE INSERT FOR_ _OLANZAPINE AND FLUOXETINE HYDROCHLORIDE CAPSULES._ RECENT MAJOR CHANGES BOXED WARNING: Warnings: Suicidal Thoughts and Behaviors 07/2013 INDICATIONS AND USAGE: Fluoxetine capsules, USP and Olanzapine in Combination: Depressive Episodes Associated with Bipolar I Disorder (1.5) 07/2013 DOSAGE AND ADMINISTRATION: Fluoxetine capsules, USP and Olanzapine in Combination: Depressive Episodes Associated with Bipolar I Disorder (2.5) 07/2013 Dosing in Specific Populations (2.7) 07/2013 Switching a Patient To or From a Monoamine Oxidase Inhibitor (MAOI) Intended to Treat Psychiatric Disorders (2.9) 01/2013 Use of fluoxetine with Other MAOIs such as Linezolid or Methylene Blue (2.10) 01/2013 CO NTRAINDIC ATIO NS: Monoamine Oxidase Inhibitors (MAOIs) (4.1) 01/2013 Other Contraindications (4.2) 07/2013 WARNINGS AND PRECAUTIONS: Clinical Worsening and Suicide Risk (5.1) 07/2013 Serotonin Syndrome (5.2) 01/2013 QT Prolongation (5.10) 07/2013 INDICATIONS AND USAGE Fluoxetine capsules, USP is a selective serotonin reuptake inhibitor indicated for: (1) Acute and maintenance treatment of Major Depressive Disorder (MDD) in adult and pediatric patients aged 8 to 18 years (1.1) Acute and maintenance treatment of Obsessive Compulsive Disorder (OCD) in adult and pediatric patie Read the complete document